SGX reported that May 2026 was another outstanding month in which the securities daily average value (SDAV) reached S$2.4 billion, the highest level since October 2007.Total securities turnover rose 70% year-on-year to S$45.8 billion.Strong trading activity directly benefits SGX through higher transaction, clearing, and market data revenue.SGX is on track for close to 30 new listings in 2026, a significant improvement over recent years.
Several companies, including Foundation Healthcare, EGP Energy, and All-Link Air & Sea, have recently filed listing documents.Also ,SGX has announced a market improvements that the board lot sizes will be reduced in October 2026, allowing investors to trade in smaller quantities and improving market accessibility.For long-term investors seeking a stable core holding with moderate growth and income, SGX continues to stand out as an attractive option, though I would be mindful of valuation after its recent strong share price performance.
